Publications by authors named "Gavin Halbert"

Claim this Profile
A
Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stability.
Paul Considine, Panida Punnabhum, Callum G Davidson, Georgina B Armstrong, Michaela Kreiner, Gavin Halbert

MAbs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality by digital design in action: a workflow for crystallisation and isolation.
Ian Houson, Humera Siddique, Magdalene W S Chong, Murray Robertson, Alice J Turner, Gavin Halbert

Int J Pharm· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality by digital design to accelerate sustainable medicines development.
Chantal L Mustoe, Alice J Turner, Stephanie J Urwin, Ian Houson, Helen Feilden, Gavin W Halbert

Int J Pharm· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of aerosol jet printing for the preparation of solid dosage forms.
Alice J Turner, Elke Prasad, Alastair J Florence, Gavin W Halbert

Int J Pharm· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probing the interplay between drug saturation, processing temperature and microstructure of amorphous solid dispersions with synchrotron X-ray phase-contrast tomography.
Ecaterina Bordos, Gunjan Das, Sven L M Schroeder, Alastair Florence, Gavin W Halbert

Int J Pharm· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterisation of colloidal structures and their solubilising potential for BCS class II drugs in fasted state simulated intestinal fluid.
Zoe McKinnon, Ibrahim Khadra, Gavin W Halbert, Hannah K Batchelor

Int J Pharm· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Additive Manufacturing MicroFactory: Overcoming Brittle Material Failure and Improving Product Performance through Tablet Micro-Structure Control for an Immediate Release Dose Form.
Elke Prasad, John Robertson, Gavin W Halbert

Polymers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel simulated media system for in vitro evaluation of bioequivalent intestinal drug solubility.
Qamar Abuhassan, Maria Inês Silva, Rana Abu-Rajab Tamimi, Ibrahim Khadra, Hannah K Batchelor, Gavin W Halbert

Eur J Pharm Biopharm· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structured solubility behaviour in fed simulated intestinal fluids.
Maria Inês Silva, Ibrahim Khadra, Kate Pyper, Gavin W Halbert

Eur J Pharm Biopharm· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excipient Impact on Fenofibrate Equilibrium Solubility in Fasted and Fed Simulated Intestinal Fluids Assessed Using a Design of Experiment Protocol.
Bayan E Ainousah, Ibrahim Khadra, Gavin W Halbert

Pharmaceutics· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fed intestinal solubility limits and distributions applied to the Developability classification system.
Maria Inês Silva, Ibrahim Khadra, Kate Pyper, Gavin W Halbert

Eur J Pharm Biopharm· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High spatial resolution ToF-SIMS imaging and image analysis strategies to monitor and quantify early phase separation in amorphous solid dispersions.
Eleonora Paladino, Frederik J S Doerr, Ecaterina Bordos, Iyke I Onyemelukwe, Dimitrios A Lamprou, Gavin W Halbert

Int J Pharm· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linked experimental and modelling approaches for tablet property predictions.
Hikaru G Jolliffe, Ebenezer Ojo, Carlota Mendez, Ian Houson, Richard Elkes, Gavin Halbert

Int J Pharm· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microfluidic Manufacture of Lipid-Based Nanomedicines.
Karim Osouli-Bostanabad, Sara Puliga, Dolores R Serrano, Andrea Bucchi, Gavin Halbert

Pharmaceutics· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small scale in vitro method to determine a potential bioequivalent equilibrium solubility range for fed human intestinal fluid.
Maria Inês Silva, Ibrahim Khadra, Kate Pyper, Gavin W Halbert

Eur J Pharm Biopharm· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacture of tablets with structurally-controlled drug release using rapid tooling injection moulding.
Erin Walsh, Natalie Maclean, Alice Turner, Moulham Alsuleman, Elke Prasad, Gavin Halbert

Int J Pharm· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structured solubility behaviour in bioequivalent fasted simulated intestinal fluids.
Qamar Abuhassan, Ibrahim Khadra, Kate Pyper, Patrick Augustijns, Joachim Brouwers, Gavin W Halbert

Eur J Pharm Biopharm· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal Structure and Twisted Aggregates of Oxcarbazepine Form III.
Hector Polyzois, Rui Guo, Vijay K Srirambhatla, Monika Warzecha, Elke Prasad, Gavin W Halbert

Cryst Growth Des· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs.
Simon Eschweiler, Ciro Ramírez-Suástegui, Yingcong Li, Emma King, Lindsey Chudley, Gavin Halbert

Nature· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mefenamic acid solid dispersions: Impact of formulation composition on processing parameters, product properties and performance.
Elke Prasad, John Robertson, Gavin W Halbert

Int J Pharm· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fasted intestinal solubility limits and distributions applied to the biopharmaceutics and developability classification systems.
Qamar Abuhassan, Ibrahim Khadra, Kate Pyper, Patrick Augustijns, Joachim Brouwers, Gavin W Halbert

Eur J Pharm Biopharm· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small scale in vitro method to determine a bioequivalent equilibrium solubility range for fasted human intestinal fluid.
Qamar Abuhassan, Ibrahim Khadra, Kate Pyper, Gavin W Halbert

Eur J Pharm Biopharm· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Consistency for a Mefenamic Acid Immediate Release Formulation.
Elke Prasad, John Robertson, Gavin W Halbert

J Pharm Sci· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics.
Carla B Roces, Gustavo Lou, Nikita Jain, Suraj Abraham, Anitha Thomas, Gavin W Halbert

Pharmaceutics· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid scale-up and production of active-loaded PEGylated liposomes.
Carla B Roces, Emily Charlotte Port, Nikolaos N Daskalakis, Julie A Watts, Jonathan W Aylott, Gavin W Halbert

Int J Pharm· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis